OTCMKTS:ENDVD Endonovo Therapeutics (ENDVD) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free ENDVD Stock Alerts $0.0025 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.0019▼$0.002550-Day Range N/A52-Week Range$1.10▼$37.90Volume20,300 shsAverage Volume11,850 shsMarket Capitalization$3,067.50P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Endonovo Therapeutics alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About Endonovo Therapeutics Stock (OTCMKTS:ENDVD)Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development of bio-electronic approach to regenerative medicine. The firm also develops, manufactures and distributes evolutionary medical devices focused on the healing of wounds and reduction of pain, edema and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, SofPulse, Electroceutical Therapy, and Scientific Studies. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.Read More ENDVD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENDVD Stock News HeadlinesMarch 6, 2023 | investing.comEndonovo Therapeutics, Inc. Announces Distribution Agreement with Academy MedicalSee More Headlines Receive ENDVD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:ENDVD CUSIPN/A CIKN/A Webendonovo.com Phone(800) 489-4774FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-400,000.00 Net Margins-6,075.54% Pretax MarginN/A Return on EquityN/A Return on Assets-279.35% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$170,000.00 Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value($0.59) per share Price / Book0.00Miscellaneous Outstanding Shares1,227,000Free FloatN/AMarket Cap$2,435.60 OptionableNot Optionable Beta1.98 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesAlan Brian CollierChairman, CEO, CFO & SecretaryDon CalabriaVice President-OperationsDavid ClarkVice President-SalesSteven FordVice President-MarketingSteven BarnesInvestor Relations ContactKey CompetitorsOncoSec MedicalNASDAQ:ONCSQRegeneRx BiopharmaceuticalsOTCMKTS:RGRXSienna BiopharmaceuticalsOTCMKTS:SNNAQSophiris BioOTCMKTS:SPHSTetraLogic PharmaceuticalsOTCMKTS:TLOGView All Competitors ENDVD Stock Analysis - Frequently Asked Questions How have ENDVD shares performed in 2024? Endonovo Therapeutics' stock was trading at $0.0087 at the beginning of 2024. Since then, ENDVD shares have decreased by 71.3% and is now trading at $0.0025. View the best growth stocks for 2024 here. How do I buy shares of Endonovo Therapeutics? Shares of ENDVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ENDVD) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.